361 related articles for article (PubMed ID: 10452321)
1. Bremsstrahlung radiation exposure from pure beta-ray emitters.
Zanzonico PB; Binkert BL; Goldsmith SJ
J Nucl Med; 1999 Jun; 40(6):1024-8. PubMed ID: 10452321
[TBL] [Abstract][Full Text] [Related]
2. Beta induced Bremsstrahlung exposure in DNA and RNA.
Manjunatha HC; Rudraswamy B
Phys Med; 2011 Oct; 27(4):188-93. PubMed ID: 21216170
[TBL] [Abstract][Full Text] [Related]
3. Marrow toxicity of 33P-versus 32P-orthophosphate: implications for therapy of bone pain and bone metastases.
Goddu SM; Bishayee A; Bouchet LG; Bolch WE; Rao DV; Howell RW
J Nucl Med; 2000 May; 41(5):941-51. PubMed ID: 10809212
[TBL] [Abstract][Full Text] [Related]
4. Posttherapy radiation safety considerations in radiomicrosphere treatment with 90Y-microspheres.
Gulec SA; Siegel JA
J Nucl Med; 2007 Dec; 48(12):2080-6. PubMed ID: 18006608
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic radionuclides: production and decay property considerations.
Volkert WA; Goeckeler WF; Ehrhardt GJ; Ketring AR
J Nucl Med; 1991 Jan; 32(1):174-85. PubMed ID: 1988628
[TBL] [Abstract][Full Text] [Related]
6. Estimation of doses to personnel and patients during endovascular brachytherapy applications.
Kirisits C; Hefner A; Wexberg P; Pokrajac B; Glogar D; Pötter R; Georg D
Radiat Prot Dosimetry; 2004; 108(3):237-45. PubMed ID: 15031445
[TBL] [Abstract][Full Text] [Related]
7. Air kerma rate constants for gamma emitters used most often in practice.
Ninkovic MM; Raicevic JJ; Adrovic F
Radiat Prot Dosimetry; 2005; 115(1-4):247-50. PubMed ID: 16381721
[TBL] [Abstract][Full Text] [Related]
8. Beta emitters and radiation protection.
Jødal L
Acta Oncol; 2009; 48(2):308-13. PubMed ID: 18766999
[TBL] [Abstract][Full Text] [Related]
9. Determination of the efficiency of commercially available dose calibrators for beta-emitters.
Valley JF; Bulling S; Leresche M; Wastiel C
J Nucl Med Technol; 2003 Mar; 31(1):27-32. PubMed ID: 12624125
[TBL] [Abstract][Full Text] [Related]
10. Biokinetic and dosimetric modelling in the estimation of radiation risks from internal emitters.
Harrison J
J Radiol Prot; 2009 Jun; 29(2A):A81-A105. PubMed ID: 19454809
[TBL] [Abstract][Full Text] [Related]
11. Bremsstrahlung parameters of praseodymium-142 in different human tissues: a dosimetric perspective for (142)Pr radionuclide therapy.
Bakht MK; Jabal-Ameli H; Ahmadi SJ; Sadeghi M; Sadjadi S; Tenreiro C
Ann Nucl Med; 2012 Jun; 26(5):412-8. PubMed ID: 22528970
[TBL] [Abstract][Full Text] [Related]
12. Bremsstrahlung radiation dose in yttrium-90 therapy applications.
Stabin MG; Eckerman KF; Ryman JC; Williams LE
J Nucl Med; 1994 Aug; 35(8):1377-80. PubMed ID: 8046497
[TBL] [Abstract][Full Text] [Related]
13. Quantitative comparisons of cancer induction in humans by internally deposited radionuclides and external radiation.
Harrison JD; Muirhead CR
Int J Radiat Biol; 2003 Jan; 79(1):1-13. PubMed ID: 12556326
[TBL] [Abstract][Full Text] [Related]
14. Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with alpha-, beta-, and auger electron-emitting radionuclides.
Boyd M; Ross SC; Dorrens J; Fullerton NE; Tan KW; Zalutsky MR; Mairs RJ
J Nucl Med; 2006 Jun; 47(6):1007-15. PubMed ID: 16741311
[TBL] [Abstract][Full Text] [Related]
15. Neutron activation of patients following boron neutron capture therapy of brain tumors at the high flux reactor (HFR) Petten (EORTC Trials 11961 and 11011).
Wittig A; Moss RL; Stecher-Rasmussen F; Appelman K; Rassow J; Roca A; Sauerwein W
Strahlenther Onkol; 2005 Dec; 181(12):774-82. PubMed ID: 16362787
[TBL] [Abstract][Full Text] [Related]
16. Dose assessment of bremsstrahlung induced by beta-emitting radioisotopes of uranium-238 series and lead in human tissues.
Manjunatha HC
Isotopes Environ Health Stud; 2014; 50(4):555-64. PubMed ID: 25348813
[TBL] [Abstract][Full Text] [Related]
17. MONTE CARLO SIMULATION OF THE BREMSSTRAHLUNG RADIATION FOR THE MEASUREMENT OF AN INTERNAL CONTAMINATION WITH PURE-BETA EMITTERS IN VIVO.
Fantínová K; Fojtík P; Malátová I
Radiat Prot Dosimetry; 2016 Sep; 170(1-4):354-8. PubMed ID: 26443547
[TBL] [Abstract][Full Text] [Related]
18. Optimal radiation shielding for beta and bremsstrahlung radiation emitted by (89)Sr and (90)Y: validation by empirical approach and Monte Carlo simulations.
Murata T; Miwa K; Matsubayashi F; Wagatsuma K; Akimoto K; Fujibuchi T; Miyaji N; Takiguchi T; Sasaki M; Koizumi M
Ann Nucl Med; 2014 Aug; 28(7):617-22. PubMed ID: 24816948
[TBL] [Abstract][Full Text] [Related]
19. The relevance of dose for low-energy beta emitters.
Goodhead DT
J Radiol Prot; 2009 Sep; 29(3):321-33. PubMed ID: 19690362
[TBL] [Abstract][Full Text] [Related]
20. Beta radiation exposure of staff during and after therapies with 90Y-labelled substances.
Rimpler A; Barth I; Baum RB; Senftleben S; Geworski L
Radiat Prot Dosimetry; 2008; 131(1):73-9. PubMed ID: 18718959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
